ARCHIVES

Phase III Vaccine Trial Fails To Improve Overall Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Advisors Voted For Provenge Approval Despite Fundamental Flaws In Trials.

April 13, 2007

NCAB To Consider Fate Of Existing Two Proposed Comp Center At Important Meeting

April 28, 1978

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

April 20, 2007

Decade-Long Cover-up?

January 6, 1995

Breast Asymmetry Predicts Breast Cancer, Study Finds

March 31, 2006

ASCO proposes compromise to limit payment cuts proposed by Congress, CMS.

September 12, 2003